Diabetes & CV Disease

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
47:11

Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

FEATURING Garth Davis
  • 47,274 views
  • March 22, 2022
  • 267
37:21

University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biological Switch: How it Works and How it Might be Prevented

FEATURING Richard Johnson
  • 9,470 views
  • April 18, 2023
  • 56
64:45

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

FEATURING Silvio Inzucchi
  • 39,616 views
  • June 16, 2017
  • 195
15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

  • 7,594 views
  • August 14, 2023
  • 111
12:04

Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

  • 20,574 views
  • September 22, 2016
  • 62
06:31

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

  • 1,878 views
  • January 26, 2024
  • 33
15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer Option Compared to Existing Weight Loss Drugs?

  • 7,893 views
  • April 13, 2021
  • 58
30:36

Practical Ways to Achieve Targets in Diabetes Care

ATDC 2022: The Ominous Octet and More

FEATURING Ralph DeFronzo
  • 2,260 views
  • July 27, 2022
  • 20
36:34

Scripps Health

GLP-1 Hysteria

FEATURING Samantha Harris
  • 3,626 views
  • December 8, 2023
  • 27
34:49

Scripps Health

Medications for Weight Loss: The New Satiety Hormones

FEATURING Ken Fujioka
  • 14,778 views
  • November 28, 2022
  • 72
28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Acids in Reducing Cardiovascular Risk

FEATURING R. Preston Mason
  • 17,394 views
  • March 25, 2019
  • 99
25:13

Holly Wyatt

Myths of Obesity Care: Health at Almost Every Size?

  • 2,358 views
  • January 28, 2023
  • 17
35:46

37th Annual Advances in Heart Disease

Lipoprotein(a) and CVD: Do Elevated Lp(a) Levels Contribute to CVD Risk? What Are the Effects of Statins, PCSK9-i, LDL Apheresis and ASOs Therapies?

FEATURING Binh An Phan, Peter Ganz
  • 1,815 views
  • January 29, 2021
  • 16
12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

  • 9,581 views
  • April 11, 2022
  • 38
29:04

15th Annual Orange County Symposium for Cardiovascular Disease Prevention

LDL-C: Earlier and Lower Is Better and Safer?

FEATURING Paul Rosenblit
  • 3,441 views
  • November 27, 2023
  • 17
26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition

FEATURING Ralph DeFronzo
  • 9,404 views
  • November 10, 2017
  • 64
11:37

ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment

FEATURING Paul Heidenreich
  • 18,686 views
  • April 21, 2022
  • 58
18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almost

FEATURING Ralph DeFronzo
  • 11,527 views
  • August 12, 2019
  • 57
66:59

UT Health San Antonio School of Medicine

Effective Treatment of T2DM Requires Combination Therapy

FEATURING Ralph DeFronzo
  • 2,500 views
  • August 30, 2023
  • 20
31:29

Scripps Health: 2020 Updates in Diabetes Management

5-Pillar Approach to Weight Loss in Diabetes: ADA Dietary & Exercise Recommendations, Behavioral Interventions, (Non-)Diabetes & Weight Loss Medications, Surgical Interventions

FEATURING Samantha Harris
  • 687 views
  • January 25, 2021
  • 4
19:37

Practical Ways to Achieve Targets in Diabetes Care

ATDC 2022 Pioglitazone: Summary of Current Knowledge

FEATURING Steven Nissen
  • 2,323 views
  • August 23, 2022
  • 22
20:24

Diana Isaacs

Tirzepatide for Type 2 Diabetes

  • 6,575 views
  • August 23, 2022
  • 44
WEBINAR

VuMedi Webinars

International Webinar on Cardiovascular Disease, Diabetes and Renal Disease


Faculty: David Fitchett, Bruce Neal, Kenneth Margulies, Jelena Seferovic
  • 4,286 views
  • March 20, 2017
  • 6
16:59

ACC 2023 Conference Coverage

ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost

FEATURING Vicki Groo
  • 1,345 views
  • April 3, 2023
  • 4
14:50

Robert Eckel

COVID-19 & Diabetes: How to Manage SGLT2, GLP-1 RAs, Metformin, ACE Inhibitors, ARBs, DPP-4, and Insulin in Hospitalized Pts With Coronavirus? Should We Await for More Research on Hydroxychloroquine Efficacy?

  • 2,514 views
  • May 12, 2020
  • 13

All Topics: